Follow-The-Filings

Holders · period archive

TLIS · Talis Biomedical Corp.

Q4 2023 13F holders among managers we track latest ownership dossier

Ticker
TLIS
Type
Equity
Class
COM NEW
Total reported value ($000, long equity)
Manager Report date Value Shares